{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:29:41Z","timestamp":1763544581094},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.mehy.2012.11.042","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T00:19:41Z","timestamp":1356049181000},"page":"252-258","source":"Crossref","is-referenced-by-count":10,"title":["Antipsychotic medications, glutamate, and cell death: A hidden, but common medication side effect?"],"prefix":"10.1016","volume":"80","author":[{"given":"Amanda M.","family":"Isom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Gudelsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil M.","family":"Richtand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2012.11.042_b0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995\u20132008","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.mehy.2012.11.042_b0010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2012.11.042_b0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.11.042_b0020","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0893-133X(99)00046-9","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.11.042_b0025","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMe058200","article-title":"The choice of antipsychotic drugs for schizophrenia","volume":"353","author":"Freedman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2012.11.042_b0030","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2012.11.042_b0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0896-6273(04)00265-X","article-title":"Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals","volume":"42","author":"Bamford","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2012.11.042_b0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuron.2004.05.008","article-title":"Selective dopamine filter of glutamate striatal afferents","volume":"42","author":"Dani","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2012.11.042_b0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2006.01.015","article-title":"Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra","volume":"1076","author":"Hatzipetros","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2012.11.042_b0050","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/j.1471-4159.1992.tb10048.x","article-title":"Dopaminergic modulation of glutamate release in striatum as measured by microdialysis","volume":"58","author":"Yamamoto","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.11.042_b0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1527-3458.2005.tb00055.x","article-title":"A review of the neuroprotective properties of the 5-HT1A receptor agonist repinotan HCl (BAYx3702) in ischemic stroke","volume":"11","author":"Berends","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.mehy.2012.11.042_b0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","article-title":"Serotonin model of schizophrenia: emerging role of glutamate mechanisms","volume":"31","author":"Aghajanian","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.mehy.2012.11.042_b0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/jnr.10126","article-title":"In vitro evidence that 5-hydroxytryptamine increases efflux of glial glutamate via 5-HT(2A) receptor activation","volume":"67","author":"Meller","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mehy.2012.11.042_b0070","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/syn.20104","article-title":"Potential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex","volume":"55","author":"Wang","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.mehy.2012.11.042_b0075","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1523\/JNEUROSCI.14-07-04159.1994","article-title":"Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations","volume":"14","author":"Yamamoto","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.11.042_b0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-2999(94)90722-6","article-title":"Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats","volume":"263","author":"See","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2012.11.042_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00210-002-0619-x","article-title":"Differential effects of chronic haloperidol and clozapine administration on glutamatergic transmission in the fronto\u2013parietal cortex in rats: microdialysis and electrophysiological studies","volume":"366","author":"Pietraszek","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.mehy.2012.11.042_b0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(93)90483-2","article-title":"Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats","volume":"152","author":"Daly","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2012.11.042_b0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-2999(93)90557-X","article-title":"Subcortical excitatory amino acid levels after acute and subchronic administration of typical and atypical neuroleptics","volume":"230","author":"Bardgett","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"Suppl B","key":"10.1016\/j.mehy.2012.11.042_b0100","first-page":"8","article-title":"Brain region effects of clozapine on amino acid and monoamine transmission","volume":"55","author":"Yamamoto","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0105","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.npp.1301305","article-title":"Dopamine and serotonin receptor binding and antipsychotic efficacy","volume":"32","author":"Richtand","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.11.042_b0110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","article-title":"A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy","volume":"57","author":"Kapur","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(98)00483-X","article-title":"Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study","volume":"355","author":"Newman-Tancredi","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2012.11.042_b0120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.11.042_b0125","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2012.11.042_b0130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/oxfordjournals.schbul.a033504","article-title":"Prevalence and correlates of diabetes in national schizophrenia samples","volume":"26","author":"Dixon","year":"2000","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.mehy.2012.11.042_b0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0010-440X(96)90054-1","article-title":"Diabetes mellitus in schizophrenic patients","volume":"37","author":"Mukherjee","year":"1996","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0140","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1176\/ajp.156.9.1417","article-title":"Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients","volume":"156","author":"Cassidy","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10401230590932380","article-title":"Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications","volume":"17","author":"McIntyre","year":"2005","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(01)00456-6","article-title":"Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use","volume":"70","author":"Regenold","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2012.11.042_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01317.x","article-title":"The metabolic syndrome and schizophrenia","volume":"119","author":"Meyer","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.mehy.2012.11.042_b0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archpsyc.64.2.242","article-title":"Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom\u2019s General Practice Research Database","volume":"64","author":"Osborn","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0165","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/14622416.7.6.863","article-title":"Genetics of antipsychotic treatment emergent weight gain in schizophrenia","volume":"7","author":"Muller","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.mehy.2012.11.042_b0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0269881105058380","article-title":"Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?","volume":"19","author":"Gough","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2012.11.042_b0175","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","article-title":"Metabolic syndrome with the atypical antipsychotics","volume":"17","author":"Pramyothin","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.mehy.2012.11.042_b0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.mehy.2012.11.042_b0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15622970410029915","article-title":"Atypical antipsychotics and diabetes mellitus","volume":"5","author":"Schwenkreis","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0190","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-5491.2005.01501.x","article-title":"Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study","volume":"22","author":"Donnelly","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.mehy.2012.11.042_b0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1464-5491.1993.tb00050.x","article-title":"Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin","volume":"10","author":"Hepburn","year":"1993","journal-title":"Diabet Med"},{"key":"10.1016\/j.mehy.2012.11.042_b0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00687813","article-title":"The dentate gyrus in hypoglycemia: pathology implicating excitotoxin-mediated neuronal necrosis","volume":"67","author":"Auer","year":"1985","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.mehy.2012.11.042_b0205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0006-3223(99)00153-5","article-title":"Epidemiology and natural history of schizophrenia","volume":"46","author":"Bromet","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0210","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4088\/JCP.v66n1001","article-title":"Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the national epidemiologic survey on alcohol and related conditions","volume":"66","author":"Grant","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0215","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/070674370304800705","article-title":"Clinical features of bipolar disorder with and without comorbid diabetes mellitus","volume":"48","author":"Ruzickova","year":"2003","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0220","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/B:MEBR.0000043967.78763.5b","article-title":"Hypoglycemic brain damage","volume":"19","author":"Auer","year":"2004","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mehy.2012.11.042_b0225","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1134\/S0006297907050021","article-title":"Cellular mechanisms of brain hypoglycemia","volume":"72","author":"Isaev","year":"2007","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.mehy.2012.11.042_b0230","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1172\/JCI30077","article-title":"Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase","volume":"117","author":"Suh","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2012.11.042_b0235","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/jnr.21634","article-title":"Calcium-dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hippocampal neurons","volume":"86","author":"Hernandez-Fonseca","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mehy.2012.11.042_b0240","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1073\/pnas.96.5.2414","article-title":"Preferential Zn2+ influx through Ca2+-permeable AMPA\/kainate channels triggers prolonged mitochondrial superoxide production","volume":"96","author":"Sensi","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2012.11.042_b0245","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1046\/j.1471-4159.2001.00670.x","article-title":"Oxidative stress in Ca(2+)-induced membrane permeability transition in brain mitochondria","volume":"79","author":"Maciel","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.11.042_b0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0300-9084(02)01381-0","article-title":"Mitochondrial permeability transition in acute neurodegeneration","volume":"84","author":"Friberg","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.mehy.2012.11.042_b0255","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3171\/jns.1981.54.3.0370","article-title":"The effect of severe hypoglycemia upon cerebrospinal fluid formation, ventricular iodide clearance, and brain electrolytes in rabbits","volume":"54","author":"Carey","year":"1981","journal-title":"J Neurosurg"},{"key":"10.1016\/j.mehy.2012.11.042_b0260","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0306-4522(99)00340-1","article-title":"Glutamate in synaptic terminals is reduced by lack of glucose but not hypoxia in rat hippocampal slices","volume":"94","author":"Madl","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2012.11.042_b0265","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/glia.20440","article-title":"Hypoglycemia, brain energetics, and hypoglycemic neuronal death","volume":"55","author":"Suh","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.mehy.2012.11.042_b0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arcmed.2005.05.014","article-title":"Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death","volume":"37","author":"Camacho","year":"2006","journal-title":"Arch Med Res"},{"key":"10.1016\/j.mehy.2012.11.042_b0275","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1471-4159.1987.tb05576.x","article-title":"Cellular origins of endogenous amino acids released into the extracellular fluid of the rat striatum during severe insulin-induced hypoglycemia","volume":"48","author":"Butcher","year":"1987","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.11.042_b0280","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1471-4159.1986.tb02847.x","article-title":"Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus","volume":"47","author":"Sandberg","year":"1986","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2012.11.042_b0285","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ana.410280408","article-title":"Hypoglycemia alters striatal amino acid efflux in perinatal rats: an in vivo microdialysis study","volume":"28","author":"Silverstein","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2012.11.042_b0290","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1126\/science.2996146","article-title":"Hypoglycemia-induced neuronal damage prevented by an N-methyl-d-aspartate antagonist","volume":"230","author":"Wieloch","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.11.042_b0295","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0950-351X(05)80210-1","article-title":"Hypoglycaemia: brain neurochemistry and neuropathology","volume":"7","author":"Auer","year":"1993","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2012.11.042_b0300","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1460-9568.1997.tb01478.x","article-title":"Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism","volume":"9","author":"Trotti","year":"1997","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2012.11.042_b0305","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/jcbfm.2008.61","article-title":"Sequential release of nitric oxide, zinc, and superoxide in hypoglycemic neuronal death","volume":"28","author":"Suh","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.mehy.2012.11.042_b0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mehy.2012.11.042_b0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00328-5","article-title":"Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment","volume":"97","author":"Konradi","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.mehy.2012.11.042_b0320","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1523\/JNEUROSCI.23-33-10681.2003","article-title":"Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia","volume":"23","author":"Suh","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.11.042_b0325","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1203\/PDR.0b013e3181bbce69","article-title":"Postnatal age influences hypoglycemia-induced poly(ADP-ribose) polymerase-1 activation in the brain regions of rats","volume":"66","author":"Rao","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.mehy.2012.11.042_b0330","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.107.043786","article-title":"Dynamic regulation of glutamatergic postsynaptic activity in rat prefrontal cortex by repeated administration of antipsychotic drugs","volume":"73","author":"Fumagalli","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2012.11.042_b0335","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2012.11.042_b0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1073858404269012","article-title":"N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease","volume":"11","author":"Waxman","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.mehy.2012.11.042_b0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1568007043337409","article-title":"The NR2B subtype of NMDA receptor: a potential target for the treatment of alcohol dependence","volume":"3","author":"Nagy","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.mehy.2012.11.042_b0350","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.euroneuro.2007.10.004","article-title":"Repeated treatment with haloperidol, but not olanzapine, alters synaptic NMDA receptor composition in rat striatum","volume":"18","author":"Gardoni","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2012.11.042_b0355","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00213-011-2262-z","article-title":"Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain","volume":"217","author":"Segnitz","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.mehy.2012.11.042_b0360","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1073\/pnas.90.20.9576","article-title":"Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated","volume":"90","author":"Cepeda","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2012.11.042_b0365","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1523\/JNEUROSCI.20-11-04011.2000","article-title":"Intracellular modulation of NMDA receptor function by antipsychotic drugs","volume":"20","author":"Leveque","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.11.042_b0370","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1523\/JNEUROSCI.15-03-02453.1995","article-title":"Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs","volume":"15","author":"Fitzgerald","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.11.042_b0375","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1022325116309","article-title":"Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits","volume":"28","author":"Schmitt","year":"2003","journal-title":"Neurochem Res"},{"key":"10.1016\/j.mehy.2012.11.042_b0380","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.410190202","article-title":"Glutamate and the pathophysiology of hypoxic\u2013ischemic brain damage","volume":"19","author":"Rothman","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2012.11.042_b0385","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s001340050474","article-title":"Intensive care 1980\u20131995: change in patient characteristics, nursing workload and outcome","volume":"23","author":"Jakob","year":"1997","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mehy.2012.11.042_b0390","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1378\/chest.118.4.1100","article-title":"Acute respiratory failure in the United States: incidence and 31-day survival","volume":"118","author":"Behrendt","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.mehy.2012.11.042_b0395","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","article-title":"Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)","volume":"286","author":"Ely","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2012.11.042_b0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.CCM.0000098033.94737.84","article-title":"Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals","volume":"32","author":"Ely","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mehy.2012.11.042_b0405","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00003246-200201000-00020","article-title":"Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult","volume":"30","author":"Jacobi","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mehy.2012.11.042_b0410","series-title":"Practice guideline for the treatment of patients with delirium","author":"American Psychiatric Association","year":"1999"},{"issue":"Suppl","key":"10.1016\/j.mehy.2012.11.042_b0415","first-page":"22","article-title":"Emergency intravenous sedation of the delirious, medically ill patient","volume":"49","author":"Adams","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0420","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00004714-199104000-00021","article-title":"High-dose intravenous haloperidol for agitated delirium in a cardiac patient on intra-aortic balloon pump","volume":"11","author":"Sanders","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.mehy.2012.11.042_b0425","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.6093256","article-title":"Blockade of N-methyl-d-aspartate receptors may protect against ischemic damage in the brain","volume":"226","author":"Simon","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.11.042_b0430","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0165-6147(90)90129-V","article-title":"The release and uptake of excitatory amino acids","volume":"11","author":"Nicholls","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2012.11.042_b0435","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(89)90217-6","article-title":"Hypoxia\/hypotension evoked release of glutamate and aspartate from the rat cerebral cortex","volume":"106","author":"Phillis","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2012.11.042_b0440","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1523\/JNEUROSCI.20-01-00022.2000","article-title":"Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity","volume":"20","author":"Sattler","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2012.11.042_b0445","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/neu.1997.14.677","article-title":"Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?","volume":"14","author":"Obrenovitch","year":"1997","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.mehy.2012.11.042_b0450","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.7100929","article-title":"Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury","volume":"217","author":"Feeney","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.mehy.2012.11.042_b0455","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/bmj.327.7405.4","article-title":"Managing agitation and aggression after head injury","volume":"327","author":"Fleminger","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2012.11.042_b0460","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.CCM.0000256722.88854.C0","article-title":"Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma","volume":"35","author":"Kline","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mehy.2012.11.042_b0465","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neulet.2008.10.076","article-title":"Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury","volume":"448","author":"Kline","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2012.11.042_b0470","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.PHM.0000091982.33232.CB","article-title":"Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats","volume":"82","author":"Wilson","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.mehy.2012.11.042_b0475","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/jnnp.58.6.753","article-title":"Prescribing of potentially harmful drugs to patients admitted to hospital after head injury","volume":"58","author":"Goldstein","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.mehy.2012.11.042_b0480","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/154596830201600402","article-title":"Differential effects of haloperidol and clozapine on motor recovery after sensorimotor cortex injury in rats","volume":"16","author":"Goldstein","year":"2002","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.mehy.2012.11.042_b0485","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/exnr.2000.7484","article-title":"Postinjury administration of l-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury","volume":"166","author":"Zhu","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.mehy.2012.11.042_b0490","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(01)02617-8","article-title":"Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats","volume":"911","author":"Rao","year":"2001","journal-title":"Brain Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712005233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712005233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:26:40Z","timestamp":1687912000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987712005233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0306987712005233"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2012.11.042","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}